ZePeptide
Finnrick has tested 78 samples from ZePeptide across 6 products.
Take Action
Request Full Data Access to the Finnrick database of peptide tests.
Products
| Tests | ||||||||
|---|---|---|---|---|---|---|---|---|
| Product | Rating | Count | Avg | Min | Max | Oldest | Most Recent | |
| GHK-Cu | 10 | 17 Dec 2025 | 9 Aug 2026 | |||||
| Tesamorelin | 6 | 20 Feb 2026 | 10 Jul 2026 | |||||
| BPC-157 | 10 | 22 Jan 2026 | 9 Aug 2026 | |||||
| Retatrutide | 37 | 25 Nov 2025 | 5 Aug 2026 | |||||
| TB-500 | 7 | 4 Feb 2026 | 13 Aug 2026 | |||||
| Tirzepatide | 7 | 18 Feb 2026 | 9 Aug 2026 | |||||
The ZePeptide samples tested by Finnrick were either acquired by Finnrick directly, or submitted by the public.
Customer Reviews
These indicators of customer satisfaction are based on reports submitted by the public through the Finnrick testing program, and are not verified.
Based on 75 overall satisfaction reports
People who submitted test requests to Finnrick gave ZePeptide an average satisfaction rating of 4.3 out of 5 across 75 reports associated with samples received and tested by Finnrick.
Most recent ZePeptide tests
Samples are tested in commercial labs
tests
products
Scores
First
Last
| Quantity | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Product | Certificate | Variant | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 13 Aug 2026 | TB-500 | View | 10mg | ⚠️ Sample does not contain TB-500 | A | No label / Silver crimp / Clear Pink cap | Lab E | Public | ||||
| 9 Aug 2026 | BPC-157 | View | 10mg | 10.2mg | +2.0% | 99.60% | BC10/260321 | No label / Silver crimp / Blue cap | Lab G | Public | ||
| 9 Aug 2026 | Tirzepatide | View | 10mg | 11.3mg | +13.0% | 99.80% | TR10/260420 | (no data) | Lab G | Public | ||
| 9 Aug 2026 | BPC-157 | View | 10mg | ⚠️ Sample does not contain BPC-157 | Ap | No label / Silver crimp / Blue cap | Lab G | Public | ||||
| 9 Aug 2026 | TB-500 | View | Thymosin Beta-4 | 10mg | 11.7mg | +17.0% | 99.60% | BT10/260402 | No label / Silver crimp / Yellow cap | Lab G | Public | |
| 9 Aug 2026 | GHK-Cu | View | 100mg | 100.6mg | +0.6% | 99.70% | CU100/260314 | No label / Silver crimp / Violet cap | Lab G | Public | ||
| 5 Aug 2026 | Retatrutide | View | 30mg | 29.5mg | -1.7% | 99.90% | RT30/260409 | No label / Silver crimp / White cap | Lab E | Public | ||
Corrections
- 29 Jul 2026: Retatrutide
- During data capture from photographs of sample **d424uhz**, the crimp color was incorrectly recorded as **silver** instead of **gold**. Verification against the corresponding Certificate of Analysis (COA) confirmed that the correct crimp color is **gold**. The record has been updated to reflect the information provided in the COA.
- 29 Jul 2026: Tirzepatide
- During data capture from photographs of sample **9gsfxvk**, the crimp color was incorrectly recorded as **Golden** instead of **Silver**. Verification against the corresponding Certificate of Analysis (COA) confirmed that the correct crimp color is **Silver**. The record has been updated to reflect the information provided in the COA.
About ZePeptide Test Results From Finnrick
ZePeptide is a peptide vendor with multiple products tracked in the independent testing dataset collected by Finnrick. This page compiles recent, batch-level test results across 6 products and 78 tests, including scores, test dates, batch IDs, and lab details. This enables you to compare quality over time, not just marketing claims.
Each tested sample receives a 0–10 score, with 10 being the best possible value. It is the total of three components: purity (0–4 points), quantity accuracy vs. the label or batch claim (0–4 points), and batch information quality (0–2 points).
When several test results are available for a product and vendor pair, you’ll also find a Finnrick Rating (A–E, where A is best and E is worst, X if an insufficient number of tests is available, or F in rare cases of documented and widespread fraud) and customer satisfaction reports with sub-scores that provide additional context. Use the table above to review purity, quantity accuracy, consistency between batches, and any notable outliers surfaced in Finnrick testing data.
ZePeptide Testing Activity & Score Summary
In the past 30 days, Finnrick has published 10 new test results for ZePeptide, and 34 in the past three months. The overall dataset includes 78 tested samples with an average score of 6.2/10 across all products.
Across 77 identity-tested samples, 86% were confirmed to contain the expected peptide (identity pass rate). Among those that passed, median purity was 99.8%. Approximately 95% of passing samples tested at or above 98% purity.
Here is a closer look at the most frequently tested products (top 3):
- Retatrutide (37 tests, 86% identity pass, median purity 99.8%) — Test scores are highly variable, ranging from 0.0 to 10.0 (average 6.3/10), suggesting significant batch-to-batch differences.
- BPC-157 (10 tests, 80% identity pass, median purity 99.8%) — Test scores are highly variable, ranging from 2.0 to 9.3 (average 5.7/10), suggesting significant batch-to-batch differences.
- Tirzepatide (7 tests, 86% identity pass, median purity 99.8%) — Test scores are highly variable, ranging from 0.0 to 10.0 (average 6.1/10), suggesting significant batch-to-batch differences.